RS Oncology
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Broadway Ste 14, Cambridge, Massachuse...Website
www.rsoncology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About RS Oncology
RS Oncology is a clinical-stage biotech focused on developing innovative PRX3-targeting therapies to combat oxidative-stress-dependent cancers, including mesothelioma and metastatic diseases. The company aims to provide new treatment options for patients with aggressive cancers that have limited therapies available. Their team of experts is currently evaluating RSO-021 in a Phase 2 clinical trial for various cancer types, including metastatic breast and ovarian cancers. RS Oncology is dedicated to improving survival chances for patients and their families through novel scientific mechanisms.Explore more
RS Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RS Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on RS Oncology recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at RS Oncology
Check if RS Oncology has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when RS Oncology launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once RS Oncology has new funding data
Website visits: Recent activity has been detected on your website
Check out if RS Oncology is spiking on competitors!
Click to see if RS Oncology had a recent Job posting/layoffs
RS Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined RS Oncology as Masked Content
Find 3 more new buyers
Compare Similar Companies to RS Oncology
Compare insights from companies similar to RS Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RS Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RS Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RS Oncology.
RS Oncology Tech Stack
A closer look at the technologies used by RS Oncology
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Event
Events
Promotion
Executive Move
RS Oncology has announced that George Naumov has been promoted from Chief Head of Business Development, Operating Officer to the role of Chief Operations Officer & Chief Business Officer.
Promotion
Executive Move
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RS Oncology
Sign Up For FreeTo access detailed company insights
RS Oncology is a clinical-stage biotech focused on developing innovative PRX3-targeting therapies to combat oxidative-stress-dependent cancers, including mesothelioma and metastatic diseases. The company aims to provide new treatment options for patients with aggressive cancers that have limited therapies available. Their team of experts is current... Read More
